246.00SEK+5.58%Mkt Cap: 741.20M $P/E: 87.231d ago
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap741.20M $
Enterprise Value834.94M $
Revenue (TTM)79.82M $
Gross Profit57.34M $
Net Income (TTM)2.41M $
Revenue/Share2.534 USD
Last Price246.00 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees199
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718
Valuation
P/E (Trailing)87.23
P/E (Forward)41.62
PEG—
EV/EBITDA63.61
EV/Revenue10.46
P/S9.29
P/B3.67
EPS (TTM)2.82
EPS (Forward)5.91
52W Range
160.0057% of range310.40
52W High310.40 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
Oper. Margin13.26%
EBITDA Margin16.44%
Profit Margin3.10%
ROE1.19%
ROA1.06%
Growth
Revenue Growth10.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF9.67M $
CapEx (TTM)24.19M $
FCF Margin-10.36%
FCF Yield-1.12%
Net Debt-17.74M $
Net Debt/EBITDA-1.35
Balance Sheet
Debt/Equity0.06
Current Ratio4.52
Quick Ratio3.10
Book Value/Sh67.09 SEK
Cash/Share9.782 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)337.40 SEK
Upside (mean)+37.2%
Target Range300.00 SEK – 385.00 SEK
SEK300.00+37.2% to meanSEK385.00
# Analysts5
Ownership
Shares Out.31.50M
Float25.13M
Insiders7.85%
Institutions61.78%
Technical
SMA 50273.34 (-10.0%)
SMA 200219.31 (+12.2%)
Beta1.46
S&P 52W Chg19.63%
Avg Vol (30d)62.18K
Avg Vol (10d)83.04K
Technical Indicators
RSI (14)40.6
MACD-3.4728
MACD Signal-0.9507
MACD Hist.-2.5221
BB Upper293.17 SEK
BB Middle263.00 SEK
BB Lower232.83 SEK
BB Width22.94%
ATR (14)13.74 SEK
Vol Ratio (20d)2.00x